CAS RN: 1661854-97-2
TAS6417
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20250701
5mg / 10mg / 25mg / 100mg
Confirm by inquiry
Shanghai Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1661854-97-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shenzhen
Inquiry
1661854-97-2 / N-[(8S)-4-amino-6-methyl-5-quinolin-3-yl-8,9-dihydropyrimido[5,4-b]indolizin-8-yl]prop-2-enamide
Standard CAS: 1661854-97-2
Multi CAS: No
Basic Information
copy
CAS
1661854-97-2 copy
Multi CAS
No copy
Molecular Formula
C23H20N6O copy
Molecular Weight
396.400000 copy
Exact Mass
396.169859 copy
SMILES
CC1=C[C@@H](CN2C1=C(C3=C(N=CN=C32)N)C4=CC5=CC=CC=C5N=C4)NC(=O)C=C copy
InChI
InChI=1S/C23H20N6O/c1-3-18(30)28-16-8-13(2)21-19(15-9-14-6-4-5-7-17(14)25-10-15)20-22(24)26-12-27-23(20)29(21)11-16/h3-10,12,16H,1,11H2,2H3,(H,28,30)(H2,24,26,27)/t16-/m0/s1 copy
InChIKey
MKCYPWYURWOKST-INIZCTEOSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
30 copy
Aromatic heavy atom count
19 copy
Fraction Csp3
0.13 copy
Rotatable bonds
3 copy
H-bond acceptors
6 copy
H-bond donors
2 copy
Molar refractivity
118.46 copy
TPSA
98.72 copy
LogP / Solubility
WLOGP
3.32 copy
MLOGP
2.94 copy
XLogP3
2.3 copy
Consensus LogP
2.85 copy
Log S (ESOL)
-4.66 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-5.21 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-5.35 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-2.78 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
4 copy